This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| collagen triple helix | |
|---|---|
| Name | Collagen triple helix |
collagen triple helix The collagen triple helix is a supramolecular protein motif formed by three left-handed polyproline II–type helices winding into a right-handed superhelix, central to the architecture of animal extracellular matrices and connective tissues. It underpins tensile strength in skin, bone, tendon and cornea and is a focus of research spanning Rosalind Franklin, Linus Pauling, Max Perutz, and institutions such as the Salk Institute for Biological Studies, Cold Spring Harbor Laboratory, and the National Institutes of Health. Studies at facilities like Lawrence Berkeley National Laboratory, European Molecular Biology Laboratory, and universities including Harvard University, University of Cambridge, and Stanford University have elucidated its sequence, structure and role in health and disease.
The defining motif comprises three polypeptide chains enriched in a repeating Gly–X–Y sequence where glycine occupies every third position, a pattern characterized using techniques at Royal Society, American Chemical Society, Max Planck Society, and described in seminal work by Linus Pauling and Robert Corey; structural models were refined with data from Raymond Gosling and Rosalind Franklin–era crystallography and later validated by cryo-EM at European Synchrotron Radiation Facility. Individual chains (α-chains) often derive from genes such as those catalogued at the Human Genome Project and studied in labs at Johns Hopkins University and Massachusetts Institute of Technology, with hierarchical organization into fibrils, fibers and matrices observed across species examined by teams at Smithsonian Institution and Natural History Museum, London. The triple helix displays periodic stagger and D-periodicity first noted in electron micrographs by researchers at University College London and later quantified in work from Yale University.
Biosynthesis initiates with transcription of collagen genes like those mapped by the Human Genome Project and processed in the National Institutes of Health–supported labs; translation occurs on ribosomes studied by groups at Max Planck Institute for Biophysical Chemistry and secretory pathway routing involves the Rudolf Virchow–era recognition of endoplasmic reticulum function elaborated at University of Vienna. Procollagen assembly and triple-helix nucleation are mediated by chaperones such as Hsp47 investigated at University of Tokyo and folding kinetics have been modeled by computational teams at Microsoft Research and Google DeepMind using frameworks originating from Alan Turing and John von Neumann theories. Disulfide-rich propeptides and C-terminal registration signals drive chain alignment, with cleavage by procollagen peptidases characterized in studies at CNRS, Max Planck Society, and Karolinska Institute.
Thermal stability and melting profiles measured by differential scanning calorimetry in labs at DuPont Experimental Station, Imperial College London, and University of California, Berkeley reveal contributions from hydroxyproline and interchain hydrogen bonds described in foundational physical chemistry by Linus Pauling. Mechanical testing in biomechanics groups at Mount Sinai Hospital and Columbia University ties helix integrity to macroscopic properties of tissues analyzed in clinical centers like Mayo Clinic and Cleveland Clinic. Ionic strength, pH and osmolytes influence helix stability as shown in experiments influenced by methods developed at Brookhaven National Laboratory and Argonne National Laboratory; molecular dynamics simulations using platforms from Oak Ridge National Laboratory and collaborations with European Molecular Biology Laboratory provide atomic-level insight.
Key modifications include proline hydroxylation by prolyl-4-hydroxylase discovered through biochemical studies at University of Copenhagen and lysyl oxidase–mediated crosslinking first characterized by research teams at University of Michigan and Columbia University. Glycosylation of hydroxylysine residues and subsequent processing involve enzymes and pathways investigated at Karolinska Institute, University of Pennsylvania, and Royal College of Surgeons in Ireland. Dysregulation of these modifications has been probed in clinical laboratories at Johns Hopkins Hospital and research centers like Memorial Sloan Kettering Cancer Center to connect enzymatic defects to altered helix mechanics.
The triple helix provides tensile strength and scaffolding in tissues studied across organ systems at hospitals such as Massachusetts General Hospital and St. Bartholomew's Hospital; it mediates cell–matrix interactions involving integrins characterized in cell biology work at MIT, University of Oxford, and UCLA. Distribution includes fibrillar collagens in bone and tendon examined by orthopedic centers at Mayo Clinic and Hospital for Special Surgery, basement membrane–associated collagens in kidney glomeruli analyzed at Addenbrooke's Hospital and corneal stroma investigated at Bascom Palmer Eye Institute. Evolutionary conservation across metazoans has been explored by comparative genomics groups at Smithsonian Institution, Natural History Museum, London, and Scripps Institution of Oceanography.
Mutations in collagen genes cause disorders such as osteogenesis imperfecta, Ehlers–Danlos syndromes and Alport syndrome documented in clinical genetics at St Louis Children's Hospital, Great Ormond Street Hospital, and research consortia funded by the Wellcome Trust. Aberrant crosslinking and misfolding contribute to fibrosis studied by teams at University College London and University of Freiburg and to tumor microenvironment alterations investigated at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute. Diagnostic assays and gene therapies are being developed in translational programs at National Institutes of Health, European Commission funded networks, and biotech companies emerging from MIT and Stanford University spinouts.
Engineered mimetics, recombinant collagen and peptide-based hydrogels are developed in biomaterials labs at Massachusetts Institute of Technology, ETH Zurich, and University of Cambridge for wound healing, tissue engineering and drug delivery, with translational efforts in companies incubated at Biotech Bay Area and Cambridge Biomedical Campus. Cross-disciplinary collaborations with chemical engineering groups at California Institute of Technology and Imperial College London enable fabrication of scaffolds for implants used in clinical trials at Johns Hopkins Hospital and Cleveland Clinic. Synthetic biology approaches leveraging CRISPR technologies from Broad Institute and Wellcome Sanger Institute aim to modulate collagen expression for regenerative medicine and industrial biomaterials.
Category:Proteins